Diagnosis and management of COPD in primary care Review article
Article Sidebar
Published:
Dec 31, 2021
Keywords:
COPD, spirometry, formoterol
Main Article Content
Abstract
Chronic obstructive pulmonary disease is a significant health problem. However, a large proportion of cases remain undiagnosed. Early diagnosis of chronic obstructive pulmonary disease leads to earlier treatment initiation, and in consequence, to improvement of patients quality of life. The gold standard for chronic obstructive pulmonary disease diagnosis is spirometry and the presence of irreversible obstruction after a bronchodilator. One of the most important interventions in the treatment of chronic obstructive pulmonary disease is anti-smoking education. The main group of drugs used in chronic obstructive pulmonary disease treatment are the long-acting bronchodilators.
Article Details
How to Cite
Mycroft, K., & Górska , K. (2021). Diagnosis and management of COPD in primary care. Medycyna Faktow (J EBM), 14(4(53), 350-355. https://doi.org/10.24292/01.MF.0421.3
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Zieliński J, Bednarek M. Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001; 119: 731-6.
2. WHO. Chronic obstructive pulmonary disease (COPD) (access: 12.08.2021).
3. Hill K, Goldstein RS, Guyatt GH et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010; 182(7): 673-8.
4. Bednarek M, Maciejewski J, Wozniak M et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63(5): 402-7.
5. Agusti A, Calverley PM, Celli B et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010; 11: 122.
6. Vestbo J, Edwards LD, Scanlon PD et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365: 1184-92.
7. Bridevaux PO, Gerbase MW, Probst-Hensch NM et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008; 63: 768-74.
8. Wedzicha JA, Brill SE, Allinson JP et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013; 11: 181.
9. Singh D, D’Urzo AD, Donohue JF et al. Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective. Respir Res. 2019; 20: 141.
10. Jankowski P, Górska K, Mycroft K et al. The use of a mobile spirometry with a feedback quality assessment in primary care setting – A nationwide cross-sectional feasibility study. Respir Med. 2021; 184: 106472.
11. Mycroft K, Korczynski P, Jankowski P et al. Active screening for COPD among hospitalized smokers – a feasibility study. Ther Adv Chronic Dis. 2020; 11: 2040622320971111.
12. Franczuk M, Przybyłowski T, Czajkowska-Malinowska M et al. Badanie spirometryczne w czasie pandemii wywołanej wirusem SARS-CoV-2. Praktyczne wskazówki zespołu ekspertów Sekcji Fizjopatologii Oddychania Polskiego Towarzystwa Chorób Płuc. Pneum Pol. 2020; 1(4): 225-36.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2021 (access: 20.08.2021).
14. Luczak-Wozniak K, Dabrowska M, Domagala I et al. Mishandling of pMDI and DPI inhalers in asthma and COPD – Repetitive and non-repetitive errors. Pulm Pharmacol Ther. 2018; 51: 65-72.
15. Melani AS, Bonavia M, Cilenti V et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011; 105(6): 930-8.
16. Dabrowska M, Luczak-Wozniak K, Miszczuk M et al. Impact of a Single Session of Inhalation Technique Training on Inhalation Skills and the Course of Asthma and COPD. Respir Care. 2019; 64(10): 1250-60.
17. Price DB, Román-Rodríguez M, McQueen RB et al. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. J Allergy Clin Immunol Pract. 2017; 5: 1071-81.e9.
2. WHO. Chronic obstructive pulmonary disease (COPD) (access: 12.08.2021).
3. Hill K, Goldstein RS, Guyatt GH et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010; 182(7): 673-8.
4. Bednarek M, Maciejewski J, Wozniak M et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63(5): 402-7.
5. Agusti A, Calverley PM, Celli B et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010; 11: 122.
6. Vestbo J, Edwards LD, Scanlon PD et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365: 1184-92.
7. Bridevaux PO, Gerbase MW, Probst-Hensch NM et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008; 63: 768-74.
8. Wedzicha JA, Brill SE, Allinson JP et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013; 11: 181.
9. Singh D, D’Urzo AD, Donohue JF et al. Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective. Respir Res. 2019; 20: 141.
10. Jankowski P, Górska K, Mycroft K et al. The use of a mobile spirometry with a feedback quality assessment in primary care setting – A nationwide cross-sectional feasibility study. Respir Med. 2021; 184: 106472.
11. Mycroft K, Korczynski P, Jankowski P et al. Active screening for COPD among hospitalized smokers – a feasibility study. Ther Adv Chronic Dis. 2020; 11: 2040622320971111.
12. Franczuk M, Przybyłowski T, Czajkowska-Malinowska M et al. Badanie spirometryczne w czasie pandemii wywołanej wirusem SARS-CoV-2. Praktyczne wskazówki zespołu ekspertów Sekcji Fizjopatologii Oddychania Polskiego Towarzystwa Chorób Płuc. Pneum Pol. 2020; 1(4): 225-36.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2021 (access: 20.08.2021).
14. Luczak-Wozniak K, Dabrowska M, Domagala I et al. Mishandling of pMDI and DPI inhalers in asthma and COPD – Repetitive and non-repetitive errors. Pulm Pharmacol Ther. 2018; 51: 65-72.
15. Melani AS, Bonavia M, Cilenti V et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011; 105(6): 930-8.
16. Dabrowska M, Luczak-Wozniak K, Miszczuk M et al. Impact of a Single Session of Inhalation Technique Training on Inhalation Skills and the Course of Asthma and COPD. Respir Care. 2019; 64(10): 1250-60.
17. Price DB, Román-Rodríguez M, McQueen RB et al. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. J Allergy Clin Immunol Pract. 2017; 5: 1071-81.e9.